Biomarker for systemic sclerosis diagnosis and PAH prediction
A technology for biological samples and reactive proteins, which can be used in disease diagnosis, biological testing, biological material analysis, etc., and can solve problems such as incomplete disease diagnosis.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027]40 SSc patients, 30 autoimmune disease control patients and 20 normal controls were screened for SSc-related autoantibody target antigens using high-throughput protein chip technology containing 21,065 non-redundant recombinant human proteins. The analysis confirmed that 113 SSc-related autoantibody target antigens were screened out. In order to confirm the sensitivity, specificity and clinical application value of these SSc-related autoantibodies, 113 SSc-related autoantibodies corresponding to target antigens were used to construct and prepare SSc-related autoantibody target antigen protein chips for 400 cases of SSc patients and 160 cases of autoimmune diseases. Control patients (including 36 patients with rheumatoid arthritis, 37 patients with systemic lupus erythematosus, 37 patients with Sjogren's syndrome, 25 patients with dermatomyositis and 25 patients with polymyositis), 40 control patients with other chronic diseases (7 cases of endocrine system diseases, 8 ca...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap